Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Virtus Investment Q1 2025 – Earnings Decline

Virtus Investment Partners, Inc. has reported its financial results for the first quarter of 2025, showcasing both U.S. GAAP and non-GAAP metrics. Here are the key highlights and changes compared to the previous quarter and the same period last year:

Earnings per share (EPS) * diluted: U.S. GAAP: $4.05, a 13% decrease from the prior quarter ($4.66) Non-GAAP: $5.73, a 24% decrease from the prior quarter ($7.50)

Total sales: * $6.2 billion, a 3% decrease from the prior quarter ($6.4 billion)

Net flows: * ($3.0) billion, an improvement from ($4.8) billion in the prior quarter

Operating income (loss): U.S. GAAP: $36.6 million, a 28% decrease from the prior quarter ($50.7 million) Non-GAAP: $54.6 million, a 27% decrease from the prior quarter ($74.5 million)

Assets under management (AUM): $167.5 billion, a 4% decrease from the prior quarter ($175.0 billion) Average total AUM: $173.6 billion, a 5% decrease from the prior quarter ($182.1 billion)

Balance sheet items: Cash and cash equivalents: $135.4 million, a 49% decrease from the prior quarter ($265.9 million) Gross debt: $235.4 million, unchanged from the prior quarter * Net debt: $100.0 million, compared to $(29.8) million in the prior quarter

The company also repurchased shares and net settled shares during the quarter, and its gross debt at March 31, 2025, was $235.4 million, with a net debt of $100.0 million.

These figures demonstrate the financial performance of Virtus Investment Partners, Inc. for the first quarter of 2025, showcasing changes in various key metrics compared to the previous quarter and the same period last year. Following these announcements, the company's shares moved -2.9%, and are now trading at a price of $152.26. For the full picture, make sure to review Virtus Investment's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS